June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Development of a risk stratification nomogram for the prediction of high-risk diabetic retinopathy
Author Affiliations & Notes
  • Kristen Harris Nwanyanwu
    Ophthalmology and Visual Science, Yale School of Medicine, New Haven, Connecticut, United States
  • Joana Andoh
    Ophthalmology and Visual Science, Yale School of Medicine, New Haven, Connecticut, United States
  • Evan Chen
    University of California San Francisco, San Francisco, California, United States
  • Yushan Xu
    Yale School of Public Health, Connecticut, United States
  • Yanhong Deng
    Yale School of Public Health, Connecticut, United States
  • Footnotes
    Commercial Relationships   Kristen Nwanyanwu None; Joana Andoh None; Evan Chen None; Yushan Xu None; Yanhong Deng None
  • Footnotes
    Support  This publication was made possible by Grant Number 1 K23 EY030530-01 from the National Eye Institute, Yale Diabetes Center Grant P30 DK045735, and the Doris Duke Fund to Retain Clinical Scientists. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH. This work has been supported in part by an unrestricted/challenge award to Yale Eye Center from the Research to Prevent Blindness (RPB), Inc.
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 583 – A0148. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kristen Harris Nwanyanwu, Joana Andoh, Evan Chen, Yushan Xu, Yanhong Deng; Development of a risk stratification nomogram for the prediction of high-risk diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2022;63(7):583 – A0148.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To develop and validate a risk calculator to identify individuals at high-risk for diabetic retinopathy (DR).

Methods : This study includes patients with diabetes from an urban, academic ophthalmology center. Patient demographic characteristics were generated using descriptive statistics. Univariable and multivariable cox proportional hazard model identified risk factors of high-risk diabetic retinopathy. Stepwise akaike’s information criteria (AIC) was used to select the best multivariable model. Bootstrap estimate of calibration accuracy for 3-year survival probability showed the existence of model overfitting. The model was then validated using 200 bootstrap resamples to obtain the slope shrinkage factor which could be used to update the model to have better survival prediction. Nomogram and R Shiny app were developed to predict 3-year and 5-year survival probabilities. Statistical analyses were performed using R (The R Foundation, Vienna, Austria) and SAS 9.4 (Cary, NC).

Results : A total of 1363 patients (female, 51.7%) were included in this study. The mean age [SD] was 61.2 [13.5]. The mean hemoglobin A1C [SD] was 8.7 [2.5]. The ethnic and racial breakdowns were 42.9% white, 33.1% Black/African American, 27.5% Hispanic/Latino, and 3.65% Asian. Most patients had a current primary care provider (96.4%), primarily spoke English (80.3%), and had public insurance (63.7%). Patients had a history of the following diabetic and chronic health conditions: nephropathy (10.0%), neuropathy (17.8%), nonhealing ulcer (11.2%), dyslipidemia (31.3%), uncomplicated hypertension (47.5%), and complicated hypertension (2.1%). The validated predictive model included having a primary care provider (HR 2.61; Table 1), insurance provider (private [HR 0.90]; uninsured [HR 2.05]), hemoglobin A1C (HR 1.08), dyslipidemia (HR 0.70), uncomplicated hypertension (HR 1.31), and complicated hypertension (HR 1.66; Table 1). A nomogram was developed to predict 3-year and 5-year probability of developing DR (Figure 1).

Conclusions : Using a predictive model, we show that adult patients with diabetes can be stratified according to their risk of DR. Risk stratification methods may help to improve clinical and surgical decision-making for patients with DR.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×